145 related articles for article (PubMed ID: 1618893)
1. Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells.
Kikuchi Y; Kita T; Miyauchi M; Hirata J; Sasa H; Nagata I; Fukushima M
J Cancer Res Clin Oncol; 1992; 118(6):453-7. PubMed ID: 1618893
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandins in the treatment of cancer.
Sasaki H; Fukushima M
Anticancer Drugs; 1994 Apr; 5(2):131-8. PubMed ID: 8049495
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo.
Kikuchi Y; Sasa H; Kita T; Hirata J; Tode T; Nagata I
Anticancer Drugs; 1991 Feb; 2(1):63-7. PubMed ID: 1958854
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant effects of prostaglandin D2 to cisplatin on human ovarian cancer cell growth in nude mice.
Kikuchi Y; Miyauchi M; Iwano I; Kita T; Oomori K; Kizawa I
Eur J Cancer Clin Oncol; 1988 Dec; 24(12):1829-33. PubMed ID: 3220080
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma].
Kikuchi Y; Miyauchi M; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):121-8. PubMed ID: 2313142
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor effect of PSK and its combined effect with CDDP on ovarian serous adenocarcinoma-bearing nude mice].
Ishii K; Kita T; Hirata J; Tode T; Kikuchi Y; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Apr; 45(4):333-9. PubMed ID: 8509669
[TBL] [Abstract][Full Text] [Related]
7. Effects of granulocyte-colony-stimulating factor and interleukin-2 on ascites formation and the survival time of nude mice bearing human ovarian cancer cells.
Kikuchi Y; Imaizumi E; Kataoka Y; Hirata J; Kita T; Tode T; Nagata I
Cancer Immunol Immunother; 1996 Dec; 43(5):257-61. PubMed ID: 9024501
[TBL] [Abstract][Full Text] [Related]
8. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
[TBL] [Abstract][Full Text] [Related]
9. Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and L-phenylalanine mustard are sensitive to delta 7-prostaglandin A1 and delta 12-prostaglandin J2.
Sasaki H; Takada K; Terashima Y; Ekimoto H; Takahashi K; Tsuruo T; Fukushima M
Gynecol Oncol; 1991 Apr; 41(1):36-40. PubMed ID: 2026357
[TBL] [Abstract][Full Text] [Related]
10. [In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Sasa H; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):589-94. PubMed ID: 1619319
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary].
Tode T; Kikuchi Y; Hirata J; Kita T; Imaizumi E; Nagata I
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1275-82. PubMed ID: 8258727
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antineoplastic effects of cisplatin by calmodulin antagonists in nude mice bearing human ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Hirata J; Kita T; Miyauchi M; Kato K
Cancer Res; 1987 Dec; 47(24 Pt 1):6459-61. PubMed ID: 3677086
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
Bregman MD; Funk C; Fukushima M
Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antineoplastic effects of cisplatin by a calmodulin antagonist (W-7) in nude mice bearing human ovarian carcinoma.
Oomori K; Kikuchi Y; Kita T; Iwano I; Kizawa I; Kato K
Cancer Detect Prev; 1988; 12(1-6):481-6. PubMed ID: 3180142
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
Kato T; Fukushima M; Kurozumi S; Noyori R
Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
[TBL] [Abstract][Full Text] [Related]
16. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation.
Kikuchi Y; Kizawa I; Oomori K; Miyauchi M; Kita T; Sugita M; Tenjin Y; Kato K
Cancer Res; 1987 Jan; 47(2):592-6. PubMed ID: 3791243
[TBL] [Abstract][Full Text] [Related]
18. Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin.
Adachi T; Mano H; Shinohara Y; Nakanishi T; Suzuki T; Ino K; Kato N; Okamoto T; Nawa A; Goto S
Cancer Immunol Immunother; 1993 Jul; 37(1):1-6. PubMed ID: 8513448
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of antitumour activity of cisplatin by N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine. HCl in human ovarian cancer cells with intrinsic or acquired resistance to cisplatin.
Kudoh K; Kikuchi Y; Hiramatsu H; Hirata J; Yamamoto K; Kita T; Nagata I
Eur J Cancer; 1997 Jan; 33(1):122-8. PubMed ID: 9071911
[TBL] [Abstract][Full Text] [Related]
20. Modulation of human lymphocyte response to phytohemagglutinin by antineoplastic prostaglandins.
Kikuchi Y; Kita T; Hirata J; Kuki E; Nagata I; Fukushima M
Int J Immunopharmacol; 1992 Jan; 14(1):105-10. PubMed ID: 1582730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
